DrugPatentWatch Database Preview
R-pharm Us Llc Company Profile
What is the competitive landscape for R-PHARM US LLC, and what generic alternatives to R-PHARM US LLC drugs are available?
R-PHARM US LLC has one approved drug.
There are six US patents protecting R-PHARM US LLC drugs.
Summary for R-pharm Us Llc
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for R-pharm Us Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-001 | Oct 16, 2007 | RX | Yes | Yes | 7,125,899*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-002 | Oct 16, 2007 | RX | Yes | Yes | 7,125,899*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-001 | Oct 16, 2007 | RX | Yes | Yes | RE41393*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-002 | Oct 16, 2007 | RX | Yes | Yes | RE41911*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-001 | Oct 16, 2007 | RX | Yes | Yes | 7,312,237*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-001 | Oct 16, 2007 | RX | Yes | Yes | 7,022,330*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-002 | Oct 16, 2007 | RX | Yes | Yes | 7,312,237*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for R-pharm Us Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-001 | Oct 16, 2007 | 6,605,599 | ➤ Sign Up |
| R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-002 | Oct 16, 2007 | 6,605,599 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for R-PHARM US LLC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 15 mg/vial and 45 mg/vial, single-use vials | ➤ Subscribe | 2012-04-16 |
International Patents for R-pharm Us Llc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Iceland | 6950 | ➤ Sign Up |
| Czech Republic | 20032023 | ➤ Sign Up |
| China | 1774253 | ➤ Sign Up |
| Russian Federation | 2003128311 | ➤ Sign Up |
| Canada | 2434584 | ➤ Sign Up |
| Hungary | 0103111 | ➤ Sign Up |
| Czech Republic | 20000058 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for R-pharm Us Llc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 1019389/01 | Switzerland | ➤ Sign Up | PRODUCT NAME: IXABEPILONE; REGISTRATION NUMBER/DATE: SWISSMEDIC 58880 27.02.2009 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
